Document Detail


Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
MedLine Citation:
PMID:  956399     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Plasma immunoreactive glucagon (IRG) concentrations were measured in 36 patients with chronic renal failure (CRF) and 32 normal subjects. In addition, the components of circulating IRG were analyzed by gel filtration in the fasting state and after physiological stimuli. Fasting IRG was elevated (P less than 0.001) in CRF patients (534 +/- 32 pg/ml) compared with the levels found in healthy subjects (113 +/- 9 pg/ml). Oral glucose suppressed plasma IRG in CRF patients from a basal level of 568 +/- 52 to a nadir of 354 +/- 57 pg/ml (120 min). This degree of suppression (38%) was comparable to that found in normal subjects (basal = 154 +/- 20 to 100 +/- 23 pg/ml) at 120 min (35%). Intravenous infusion of arginine (250 mg/kg) resulted in a 71% rise in IRG in CRF patients and a 166% increase in normal subjects. Gel filtration of fasting plasma from CRF patients showed three major peaks. The earliest (A) was found in the void volume (mol wt greater than 40,000) and constituted 16.5 +/- 4.7% of the elution profile. The middle peak (B) eluted just beyond the proinsulin marker (approximately 9,000 mol wt) and constituted the largest proportion of the elution profile (56.5 +/- 3.4%). The third peak (C) coincided with the standard glucagon and [125I]glucagon markers (3,485 mol wt) and comprised 27.0 +/- 4% of the IRG profile. In contrast, only peaks A and C were found in fasting plasma of normal subjects (53.6 +/- 10.4% in A and 46.4 +/- 10.4 in C). After oral glucose, glucagon immunoreactivity in the 3,500 mol wt peak (C) was markedly suppressed, while the B peak in patients with CRF declined to a lesser extent. The A peak in both groups was unchanged. After an arginine infusion only the C peak increased in both groups of subjects. Gel filtration of plasma in 3 M acetic acid gave similar profiles to those obtained in glycine albumin buffer. Exposure of serum to trypsin indicated that the B and C peaks were digestible, while the A peak was resistant to the action of the enzyme. In one sample, peak C increased after a 2-h exposure of serum to trypsin. We conclude that circulating IRG in normal subjects and patients with CRF is heterogenous. The hyperglucagonemia of renal failure is largely due to an increase in IRG material of approximately 9,000 mol wt, consistent with proglucagon, although the 3,500 mol wt component is also considerably elevated (threefold). The significance of circulating IRG levels should be interpreted with caution until the relative biological activity of the three components is established.
Authors:
S F Kuku; J B Jaspan; D S Emmanouel; A Zeidler; A I Katz; A H Rubenstein
Related Documents :
1613829 - Effect of recombinant human growth hormone on catabolic hormones and free fatty acids f...
22752189 - Increased serum interleukin-17 in graves' ophthalmopathy.
7011049 - Hepatic metabolism of glucagon in the dog: contribution of the liver to overall metabol...
10386299 - Metabolic responses of dairy cows and heifers to various intravenous dosages of glucagon.
2045529 - Chronotherapy of trichlormethiazide in hypertensive patients.
3558359 - Stimulation of glycogenolysis and vasoconstriction in the perfused rat liver by the thr...
2489199 - The effect of sucralfate on the steady-state serum concentrations of phenytoin.
10468989 - Ontogeny of serum leptin concentrations in the human.
23308389 - Regulation of the pituitary-thyroid axis in adulthood is not related to birth weight: e...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of clinical investigation     Volume:  58     ISSN:  0021-9738     ISO Abbreviation:  J. Clin. Invest.     Publication Date:  1976 Sep 
Date Detail:
Created Date:  1976-10-29     Completed Date:  1976-10-29     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7802877     Medline TA:  J Clin Invest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  742-50     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetic Acids / pharmacology
Adult
Animals
Antigens
Arginine / pharmacology
Chromatography, Gel
Fasting
Female
Glucagon / blood*,  immunology
Glucose / pharmacology
Humans
Kidney Failure, Chronic / blood*
Male
Molecular Weight
Nephrectomy
Rats
Stress, Physiological
Trypsin / pharmacology
Chemical
Reg. No./Substance:
0/Acetic Acids; 0/Antigens; 50-99-7/Glucose; 74-79-3/Arginine; 9007-92-5/Glucagon; EC 3.4.21.4/Trypsin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Composition of weight lost during short-term weight reduction. Metabolic responses of obese subjects...
Next Document:  Hemodynamic determinants of the time-course of fall in canine left ventricular pressure.